We describe a novel clinical phenotype associating T-and B-cell lymphopenia, intermittent neutropenia, and atrial septal defects in three members of a consanguineous kindred. Their clinical histories included recurrent bacterial infections, viral infections, mucocutaneous candidiasis, cutaneous warts and skin abscesses. Homozygosity mapping and candidate gene sequencing revealed a homozygous premature termination mutation in the gene STK4 (serine threonine kinase 4, formerly having the symbol MST1).
Introduction
Monogenic disorders of the human immune system have provided important insights into the function of host defense mechanisms 1 . Despite remarkable progress in the field, many disorders remain poorly understood 2, 3 . Identifying genetic mutations in patients with immunodeficiency syndromes may reveal novel insights into basic mechanisms of the human immune system.
Here, we describe the first human patients with a biallelic mutation of Serine Threonine Kinase 4 (STK4) (MIM:604965). STK4 (previously sometimes named MST1) was originally identified as a ubiquitously expressed kinase with structural homology to yeast Ste20 4, 5 . STK4 and STK3
(MST2) (MIM: 605030) are the mammalian homologs of the Drosphila Hpo protein, the central constituent of the highly conserved HIPPO pathway controlling cell growth, apoptosis, and tumorigenesis 6 . Mice lacking either Stk3 or Stk4 are viable, but those lacking both proteins are not. This indicates that each protein can substitute for the other in the most essential functions 7 .
When both Stk3 and Stk4 are conditionally deleted however, their respective role as growth control regulators becomes manifest, exemplified by liver-specific double knockout mice that develop massive hepatomegaly and hepatocellular carcinoma 8, 9 .
STK4 has both pro-apoptotic and anti-apoptotic functions. Earlier papers focused on the proapoptotic functions, and STK4 was described with the adjective "pro-apoptotic" in the title of a paper as recently as 2007 10 . The strongest evidence that STK4 delivers pro-apoptotic signals is that STK4 is cleaved by caspases 11, 12 ; caspase activity is unambiguously pro-apoptotic. In resting conditions, STK4 is a cytoplasmic protein. In response to apoptotic stimuli, the 63kDa fulllength protein is cleaved by caspases and a 36kDa N-terminal fragment translocates to the nucleus and phosphorylates histones 13, 14 , suggesting that STK4 plays a proapoptotic role. STK4
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There was also some evidence, prior to the generation of Stk4-deficient mice, that STK4 has anti-apoptotic functions. For example, a study in C. elegans showed that phosphorylation of FOXO proteins by the STK4 ortholog DAF16 protects against cell death induced by oxidative stress (ROS). Furthermore, when DAF16 cannot perform the phosphorylation function, lifespan of the worms is measurably reduced 19 .
Surprisingly, Stk4-deficient mice had progressive loss of T and B cells due to excessive apoptosis [20] [21] [22] . Thus, STK4 may also have a protective role maintaining cellular viability. STK4
phosphorylates transcription factors in the FOXO family, including FOXO1 and FOXO3, as part of a stress-response pathway 19 , 21 . STK4 participates in several other pathways. Binding of NORE1A and RASSF1A to STK4 homodimers inhibits STK4 kinase activity 20, 23 . Binding of RAPL to STK4 is essential for lymphocytes to polarize and adhere 24 and potentially to control proper egress from thymus 22 .
Our discovery of patients lacking STK4 allows a comparison between mice vs. humans and highlights the physiological role of the HIPPO pathway for the development of the immune and cardiac system.
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Materials and Methods

Participants
Principal participants of the study were eight related individuals of Iranian ancestry. Blood and bone marrow samples were taken from healthy and affected family members and unrelated healthy individuals. Biopsies of warts were taken from patients P2 and P3. Blood was taken from 100 unrelated Iranian controls and from members of 16 other consanguineous families with neutropenia for the purpose of sequencing STK4 or STK3.
Samples were taken upon informed consent/assent, following current European regulations and the Declaration of Helsinki. The study was approved by the institutional review boards at Hannover and Isfahan Medical Schools. All patients were physically seen and examined at Hannover Medical School in 2010. Basic clinical information was retrieved from the patients' medical records.
Genotyping, linkage analysis and gene sequencing
The samples from affected and healthy family members were genotyped using the Affymetrix 250k NspI SNP mapping array (GEO Platform GPL3718), following the same procedures recommended by Affymetrix, as done previously 25 . Microsatellites were genotyped using published methods [26] [27] [28] . Exons and flanking intron-exon boundaries of candidate genes were amplified by PCR and sequenced with the use of ABI PRISM 3130 DNA Sequencer and DNA Sequencing Analysis software, version 3 (Applied Biosystems). To find homozygous, perfectly segregating intervals, we used the software findhomoz described previously 25 . To compute LOD scores with SuperLink 28 , we hypothesized that I-1, I-2, and II-1 share a common ancestor.
Individuals I-1 and I-2 are assumed to have a pair of great grandparents in common, and this pair
For personal use only. on April 19, 2017 . by guest www.bloodjournal.org From is also assumed to be great-great grandparents of II-1. The assumption of common great grandparents to represent likely consanguinity has been used elsewhere 27, 29 . Other linkage parameters were set as in previous studies 26, 27 . 
Assessment of apoptosis and mitochondrial membrane potential of neutrophils and T lymphocytes
Neutrophils were isolated from peripheral blood by density gradient centrifugation. The purity was always > 95%. Neutrophils were exposed to staurosporine (5 µM) (Sigma) at various time points and analyzed by FACS after staining with annexin-V (Molecular Probes) and propidium iodide (Sigma). Cells were gated on intact neutrophils based on forward scatter and side scatter features. Dissipation of the mitochondrial membrane potential was determined by FACS after loading the cells with valinomycin (100 nM) (Sigma) and JC-1 dye (3.5 µM) (Molecular Probes) 30 .
PBMCs isolated by gradient centrifugation over Ficoll Paque (Amersham Biosciences) were incubated with anti-Fas monoclonal antibody (5 µg/ml) or Staurosporine (5 µM) for various time points and analyzed by FACS after staining with propidium iodide and CD3 antibody (BD). Loss of the MMP was determined by FACS after loading the PBMCs with valinomycin (100 nM) (Sigma) and staining with CMXRos (Molecular Probes) and gating on CD 3+ population.
Results
Clinical phenotype
We investigated three patients from a consanguineous Iranian family presenting with a primary immunodeficiency including bacterial infections, viral infections, mucocutaneous candidiasis and cutaneous warts. Female patient P1, born in 1986, had pneumonia at age 2 years and subsequently recurrent upper and lower respiratory tract infections. Her brother P2, born in 1990, presented at age 10 years with neutropenia and recurrent episodes of fever and upper respiratory tract infections. Two siblings of P1 and P2 died in their first year of life due to septicemia.
Female patient P3 was born in 2001 and presented with recurrent sinusitis and rhinitis at age 4 years. She had at least two episodes of staphylococcal pneumonia. All three patients had histories of recurrent skin abscesses.
All patients showed continuously or intermittently decreased numbers of peripheral neutrophil granulocytes (Table 1 and Table S2 ); however in contrast to severe congenital neutropenia secondary to mutations in HAX1 or ELANE, maturation of neutrophils in the bone marrow appeared normal in all three patients ( Figure 1A and Supplementary Figure 1) . Neutropenia was identified also in periods when the patients did not suffer from infections, suggesting that low counts of neutrophil granulocytes were not induced by infections. No growth defects or dysmorphic features were noted. The patients had unremarkable heights and weights.
An immunological investigation of all three patients in 2010 (Table 1) 
Genetic analysis revealed loss-of-function mutation in STK4
By gene sequencing, we excluded the possibility that these patients had an unusual form of a known primary immunodeficiency, such as WHIM syndrome caused by mutations in CXCR4 31 , G6PC3-deficiency 26 or severe congenital neutropenia caused by mutations in either ELANE or HAX1 32, 30 . None of these genes were mutated. We performed a SNP-based genome-wide homozygosity mapping study, which we refined using microsatellite markers according to published methods 25 . We identified a single region in which markers segregate perfectly with disease ( Figure 2A ). This was on chromosome 20 and spans at least 41. In 2008, before Stk4-deficient mice had been described, we sequenced 12 of the 46 genes in the maximal linkage interval (Table S3) , prioritizing genes highly expressed in the hematopoietic system or having a role in apoptosis. STK4, located in the narrowest possible linkage interval, was a plausible candidate gene. All three patients had a homozygous stop codon mutation in exon 7 of the gene STK4 (c.G750A, p.W250X). Parents and healthy siblings were heterozygous for the mutation, consistent with autosomal recessive inheritance ( Figure 2B ). We sequenced the entire exon 7 in 100 healthy Iranian controls; no control carried any sequence change in this exon. We sequenced STK4 in 10 unrelated patients with consanguineous parents, six with neutropenia and markers segregating perfectly around STK4 and four with lymphopenia and neutropenia. We have not yet identified any other patients with a mutation in STK4. Similarly, we were unable to discover any mutations in STK3 in six unrelated patients born to consanguineous parents who had markers segregating perfectly around STK3. Figure 3) and the functional data below prove that STK4 is expressed in neutrophils. In light of the previous negative report 33 , the weakness of the Western blot is not surprising.
Immunological analysis in STK4-deficient patients
We performed immune assays for all three patients (Table 1 and Supplementary Figure 2) .
Consistent with the phenotype of Stk4-deficient mice 20 , all patients showed a reduced fraction of CD45RA + CD45RO -naïve T cells ( Figure 3A) . Additional experiments to determine central and effector memory T cells show that CD62L + CCR7 + cells T cells, also named central memory T cells, are decreased in STK-deficient patients. In contrast, the CD62L -CCR7 -population of effector memory T cells appears less affected ( Figure 3B ). Molecular spectratyping on T cell receptor -Vβ subclasses shows that the pseudo-Gaussian distribution of almost all Vβ subclasses seen in a healthy donor is disturbed in STK4-deficient patients (Supplementary Figure 4) . ( Figure 3D ). Despite the peripheral B-cell lymphopenia, all patients had evidence of hypergammaglobulinemia. P1 and P3 had increased levels of IgG; P2 and P3 had increased levels of IgA. IgM levels were decreased in P1 and P2. All three patients showed elevated levels of IgE (Table 1 ). All patients were immunized and produced protective levels of specific antibodies to diphtheria, tetanus, and polio. Interestingly, all patients had measurable levels of autoantibodies (red blood cells, thyroglobulin) (Table 1) Figure 6C, D) . Phenotypically, the EBV-associated lymphoproliferative disorder resembled lymphoplasmacytic lymphoma. EBV serology on P3
showed EBV-IgG positive (1570 U/ml) and EA-C-IgG positive. Furthermore, EBV-DNA PCR
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Increased apoptosis in STK-4 deficient T cells and neutrophil granulocytes
Stk4-deficient mouse T lymphocytes are highly susceptible to apoptosis 21 , yet no phenotype of murine Stk4-deficient neutrophil granulocytes has been reported. Purified peripheral T cells were stimulated with anti-Fas monoclonal antibody and apoptosis was measured by staining with annexin-V and propidium iodide. Furthermore, purified peripheral neutrophils were exposed to staurosporine and apoptosis was measured by flow cytometry. As shown in Figure 4A and 4B, STK4-deficient cells exhibited a higher degree of apoptosis than did cells from control or heterozygous individuals. Similar findings were observed when T cells were exposed to staurosporine (Supplementary Figure 7A) .
We also tried to examine in vitro proliferation of STK4-deficient T cells. Due to rapid death of FoxO3a, a direct downstream target of Stk4, has previously been shown to protect against apoptosis in Stk4-deficient mice 21 . We further hypothesized that STK4-deficient T cells may display increased sensitivity to reactive oxygen species. In fact, human STK4-deficient T cells had decreased levels of FoxO3a, as measured by Western Blot assays ( Figure 4E) . The mRNA expression level of FoxO3a from isolated PBMCs of the patients was also decreased in comparison to healthy controls (Supplementary Figure 8) . Thus, STK4 may protect against increased oxidative stress and susceptibility to apoptosis via FoxO proteins.
STK4-deficient T cells in vitro,
For
Discussion
Human STK4-deficiency causes a primary immunodeficiency syndrome affecting T-cells, Bcells, and possibly neutrophil granulocytes. Several features, such as lymphopenia and increased susceptibility to apoptosis, recapitulate findings in Stk4-deficient mice [20] [21] [22] . However, our analysis of human patients has highlighted certain novel phenotypic characteristics deserving further investigations. All three patients showed a relative increase in transitional B cells and evidence of hypergammaglobulinemia, associated with increased titers of autoantibodies. One patient had EBV-associated lymphoproliferative disease. It remains to be shown whether unrestricted B cell expansion is due to defective T cell responses or intrinsic mechanisms in STK4-deficient B cells.
Intermittent neutropenia was observed in all three patients, though neutropenia has not been reported in Stk4-deficient mice. Neutrophils from patients exhibited more apoptosis than did neutrophils from healthy controls or heterozygous individuals. Species-dependent mechanisms controlling viability of neutrophil granulocytes have been noted in other comparative studies 35 .
Patients did not exhibit a defect in neutrophil production; bone marrow samples were studied in both Iran and Germany and there was no evidence of a block in myeloid differentiation. Two out of three patients (P2 and P3) had no evidence of anti-neutrophil antibodies, whereas patient P1 had borderline positive test results. These findings do not allow us to explain decreased neutrophil counts by postulating an autoimmune mechanism, yet they are compatible with such a mechanism.
Our attempts to discover additional patients were not successful. The group of Geneviève de St.
Basile undertook a genetic linkage study in two unrelated Turkish families and has identified In addition to immunological defects, all three STK4-deficient patients had structural cardiac aberrations. Interestingly, transgenic mice with cardiac-specific overexpression of Stk4 (TgStk4) developed dilated cardiomyopathy secondary to increased apoptosis of myocytes 36 , but no cardiac phenotype has been reported in Stk4-deficient mice 20, 21 . Stk4 is activated by Rassf1A in the heart, promoting apoptosis in cardiac cells and inhibiting cardiac fibroblast proliferation, thus controlling cardiac remodeling 23 and mutations in other murine genes in the STK4/Hippo pathway also lead to heart defects 37 .
In conclusion, we describe a novel primary immunodeficiency syndrome caused by a homozygous nonsense mutation in STK4, the ortholog to Drosophila Hpo. STK4 is critical for maintenance of lymphocytes and control of unrestricted EBV-induced lymphoproliferation. The authors declare that they have no financial conflicts of interest. For personal use only. on April 19, 2017 . by guest www.bloodjournal.org From Both the apoptosis and mitochondrial membrane potential assays were done twice, on independently purified cells.
